Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Project

IAP Antagonists Synergise with IFNy to Activate Novel RIPK1 and Caspase Mediated Death Pathways in Cancer Cell Lines

Information

Project Team

Outputs and Outcomes

Promotor

Peter Vandenabeele

Department of Biomedical molecular biology